Bessemer Group Inc Ani Pharmaceuticals Inc Transaction History

Bessemer Group Inc

$61.6 Billion
Q2 2025

A detailed history of Bessemer Group Inc transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Bessemer Group Inc holds 126 shares of ANIP stock, worth $11,352. This represents 0.0% of its overall portfolio holdings.

Number of Shares

126

Previous 10 1160.0%

Holding current value

$11,352

Previous $1,000 700.0%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 01, 2025	BUY	$57.79 - $72.95 $6,703 - $8,462	116 Added 1160.0%	126 $8,000
Q1 2025 Apr 23, 2025	SELL	$53.93 - $68.36 $4,368 - $5,537	-81 Reduced 89.01%	10 $1,000
Q3 2024 Nov 12, 2024	BUY	$54.33 - $65.72 $1,303 - $1,577	24 Added 35.82%	91 $6,000
Q1 2024 May 13, 2024	BUY	$54.2 - $69.69 $3,631 - $4,669	67 New	67 $5,000
Q3 2020 Nov 12, 2020	SELL	$26.38 - $33.1 $704,346 - $883,770	-26,700 Closed	0 $0
Q1 2020 Apr 30, 2020	BUY	$30.35 - $67.14 $133,540 - $295,416	4,400 Added 19.73%	26,700 $1.09 Million
Q4 2019 Feb 04, 2020	SELL	$55.65 - $79.83 $83,475 - $119,745	-1,500 Reduced 6.3%	22,300 $1.38 Million
Q3 2019 Nov 07, 2019	BUY	$64.7 - $85.39 $51,760 - $68,312	800 Added 3.48%	23,800 $1.74 Million
Q2 2019 Jul 19, 2019	BUY	$67.77 - $82.2 $159,530 - $193,498	2,354 Added 11.4%	23,000 $1.89 Million
Q1 2019 May 13, 2019	BUY	$45.83 - $70.54 $157,930 - $243,080	3,446 Added 20.03%	20,646 $1.46 Million
Q4 2018 Feb 12, 2019	BUY	$41.17 - $56.44 $607,833 - $833,280	14,764 Added 606.08%	17,200 $774,000
Q3 2018 Nov 06, 2018	BUY	$52.95 - $71.34 $128,986 - $173,784	2,436 New	2,436 $138,000

Others Institutions Holding ANIP

# of Institutions

245

Shares Held

20M

Call Options Held

19.9K

Put Options Held

12.8K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.57B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Account

Bessemer Group Inc Ani Pharmaceuticals Inc Transaction History